A
Adial Pharmaceuticals, Inc. (ADIL)
NCM – Real Time Price. Currency in USD
1.38
-0.06 (-4.17%)
At close: May 12, 2026, 4:00 PM EDT
1.36
-0.02 (-1.45%)
After-hours: May 12, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.38
-0.06 (-4.17%)
At close: May 12, 2026, 4:00 PM EDT
1.36
-0.02 (-1.45%)
After-hours: May 12, 2026, 7:58 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $5.9M barely cover the upcoming debt maturities $0.0
Total current assets $6.2M exceed Total current liabilities $1.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.42 | 6.05 | 10 | |
| Quick ratio | 4.42 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -564 | -564 | -565 | -565 | -565 |
| Operating Income | -11M | -7M | -8M | -8M | -8M |
| Net Income | -13M | -8M | -13M | -8M | -8M |
| EBITDA | -11M | -7M | -8M | -8M | -8M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 67.88 | 5.5 |
| Next quarter | N/A | 73.11 | 5.5 |
| Current year | N/A | 48.74 | 5.5 |
| Next year | N/A | 57.65 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -11.28 | 9.5 | 27.75 | 6.8 |
| Y/Y | 999 | 3.6 | 77.38 | 8.89 | 7.5 |
| 3y average | 999 | 2.79 | 59.55 | N/A | 6.3 |
| 5y average | 999 | -7.08 | 57.41 | -14.75 | 5.5 |
| Weighted average score | 6.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |